The adipokine SAA3 is induced by interleukin-1β in mouse adipocytes

Journal of Cellular Biochemistry

Volumn 104, Issue 6, 2008, Pages 2241-2247

  Sommer, Grit ^a   Weise, Sebastian ^a   Kralisch, Susan ^a,b   Scherer, Philipp E ^c   Lössner, Ulrike ^a   Blüher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a,b,d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d NONE   (Germany)

Author keywords

3T3 L1 adipocyte; Adipokine; Interleukin 1 ; Serum amyloid A3

Indexed keywords

ADIPOCYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; JANUS KINASE 2; MESSENGER RNA; SERUM AMYLOID A 3;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BROWN ADIPOSE TISSUE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UPREGULATION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; JANUS KINASE 2; MICE; NF-KAPPA B; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; TIME FACTORS;

EID: 49049095687     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21782     Document Type: Article

References (31)

1. Cao Z, Henzel WJ, Gao X. 1996. IRAK: A kinase associated with the interleukin-1 receptor. Science 271:1128-1131.
2. Cooke EL, Uings IJ, Xia CL, Woo P, Ray KP. 2001. Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation. Biochem J 359:403-410.
3. de Beer MC, Beach CM, Shedlofsky SI, de Beer FC. 1991. Identification of a novel serum amyloid A protein in BALB/c mice. Biochem J 280(Pt 1):45-49.
4. Doi M, Shichiri M, Katsuyama K, Ishimaru S, Hirata Y. 2002. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis 160:123-132.
5. Fasshauer M, Paschke R. 2003. Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594-1603.
6. Fasshauer M, Klein J, Ueki K, Kriauciunas KM, Benito M, White MF, Kahn CR. 2000. Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem 275:25494-25501.
7. Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M, Kahn CR. 2001. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol 21:319-329.
8. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R. 2004a. Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes. J Endocrinol 183:561-567.
9. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R. 2004b. Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat signaling pathways in 3T3-L1 adipocytes. J Endocrinol 181:129-138.
10. Han CY, Subramanian S, Chan CK, Omer M, Chiba T, Wight TN, Chait A. 2007. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 56:2260-2273.
11. Hotamisligil GS, Shargill NS, Spiegelman BM. 1993. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259:87-91.
12. Jager J, Gremeaux T, Cormont M, Marchand-Brustel Y, Tanti JF. 2007. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241-251.
13. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G, Olson MB, Reis SE. 2004. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109:726-732.
14. Kluve-Beckerman B, Drumm ML, Benson MD. 1991. Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol 10:651-661.
15. Laborda J. 1991. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19:3998.
16. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, Capeau J, Caron M. 2006. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49:2162-2173.
17. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526.
18. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. 2004. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219:9-15.
19. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. 2001. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 276:42077-42083.
20. Lowell CA, Potter DA, Stearman RS, Morrow JF. 1986a. Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem 261:8442-8452.
21. Lowell CA, Stearman RS, Morrow JF. 1986b. Transcriptional regulation of serum amyloid A gene expression. J Biol Chem 261:8453-8461.
22. Meek RL, Eriksen N, Benditt EP. 1992. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci USA 89:7949-7952.
23. Meek RL, Urieli-Shoval S, Benditt EP. 1994. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function. Proc Natl Acad Sci USA 91:3186-3190.
24. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. 2003. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 14:561-566.
25. Reddy SA, Huang JH, LiaoWS. 1997. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem 272:29167-29173.
26. Stylianou E, Saklatvala J. 1998. Interleukin-1. Int J Biochem Cell Biol 30:1075-1079.
27. Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP. 1994. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 145:650-660.
28. Yamamoto K, Migita S. 1985. Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences. Proc Natl Acad Sci USA 82:2915-2919.
29. Yamamoto K, Shiroo M, Migita S. 1986. Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction. Science 232:227-229.
30. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946.
31. Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, Snitker S, Horenstein RB, Hull K, Goldberg NH, Goldberg AP, Shuldiner AR, Fried SK, Gong DW. 2006. Acute-phase serum amyloid A: An inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 3:e287.